Adherence to antiretroviral therapy, while often conceptualised as an individual or community-level concern, needs to be understood in the context of political and historical developments that have characterised many resource-constrained societies. This article identifies some of these dimensions of antiretroviral therapy adherence in South Africa and outlines the implications for community health psychology in taking this perspective. Using the conceptual apparatus of therapeutic citizenship, we demonstrate the importance of historical, political and other structural barriers to adherence. We conclude by examining the implications of these debates for community health psychology that go beyond the individual as the unit of intervention and analysis.
BangsbergDRPerrySCharleboisED, et al. (2001) Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS15: 1181–1183.
2.
BlowerSMAschenbachANKahnJO (2003) Predicting the transmission of drug-resistant HIV: Comparing theory with data. Lancet Infectious Diseases3(1): 10–11.
3.
CampbellC (2003) Letting Them Die: Why HIV/AIDS Intervention Programmes Fail. Cape Town, South Africa: Juta.
CampbellCMurrayM (2004) Community health psychology: Promoting analysis and action for social change. Journal of Health Psychology, 9, 187–195. doi: 10.1177/1359105304040886.
6.
CampbellCFoulisCMaimaneS, et al. (2005) The impact of social environments on the effectiveness of youth HIV prevention: A South African case study. AIDS Care17: 471–478.
7.
ChigwederePSeageGRGruskinS, et al. (2008) Estimating the lost benefits of antiretroviral drug use in South Africa. Journal of Acquired Immune Deficiency Syndrome49: 410–415.
8.
CoetzeeBKageeAVermeulenN (2011) Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting. The perspectives of health care providers. AIDS Care23: 146–151.
9.
EpsteinH. (2007). The invisible cure: Why we are losing the fight against AIDS in Africa. Picador: New York.
10.
HertogsKBloorSKempSD, et al. (2000) Phenotypic and genotypic analysis of clinical HIV-1 resistance reveals extensive protease inhibitor cross-resistance: A survey of over 6000 samples. AIDS14: 1203–1210.
11.
KageeADelportT (2010) Barriers to adherence to antiretroviral treatment: The perspectives of patient advocates. Journal of Health Psychology15: 1001–1011.
12.
KageeARemienRHBerkmanAHoffmanSCamposLSwartzL (2011) Structural barriers to ART adherence: Challenges and potential ways forward. Global Public Health6: 83–97.
13.
KageeARemienRHBerkmanA, et al. (2011) Structural barriers to ART adherence: Challenges and potential ways forward. Global Public Health6: 83–97.
14.
NattrassN (2007) Mortal Combat: AIDS Denialism and the Struggle for Antiretrovirals in South Africa. Pietermaritzburg, South Africa: University of KwaZulu-Natal Press.
15.
NattrassN (2012) The AIDS Conspiracy: Science Fights Back. New York: Columbia University Press.
16.
NguyenVK (2004) Antiretroviral globalism, biopolitics, and therapeutic citizenship. In: OngACollierS (eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. London: Blackwell, pp. 124–144.
17.
PatersonDLSwindellsSMohrJ, et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine133: 21–30.
18.
RobinsS (2008) From Revolution to Rights in South Africa: Social Movements, NGOs and Popular Politics. Pietermaritzburg, South Africa: University of KwaZulu-Natal Press.
